JUBLPHARMAJubilant Pharmova Ltd.

    Jubilant Pharmova Ltd: results and news

    Every Jubilant Pharmova Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: credit rating, earnings.

    3 articles · pharmaceuticals · Latest 13 Nov 2026

    JUBLPHARMAJubilant Pharmova Ltd

    ICRA assigns AA+/Stable to Jubilant Pharmova’s proposed ₹1,400 crore of NCDs

    Jubilant Pharmova Limited has told the exchanges that ICRA Limited has assigned a rating of [ICRA] AA+ (Stable) to the company’s proposed non-convertible debentures (NCDs) of ₹1,400 crore. The rating was given in ICRA’s letter dated 13 Oct 2026, which the company received at 5:09 PM IST that day, and the company made the disclosure on 14 Oct 2026 under Regulation 30 of the SEBI listing rules.

    • Credit rating
    • Pharmaceuticals

    Blacklitt Research1 min read